Cardiovascular effects of fenoterol under conditions of hypoxaemia.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Thorax

• Publication date

  1992-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.47.10.814PMID 1481183PMCID PMC464060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.

  1997cited by this paper
• Statistics--with confidence?

  1991cited by this paper
• Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.

  1991cited by this paper
• Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.

  1991cited by this paper
• Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

  1990cited by this paper
• Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.

  1990cited by this paper
• The self-administration of inhaled beta agonist drugs during severe asthma.

  1990cited by this paper
• Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

  1989cited by this paper
• Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans.

  1989cited by this paper
• Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.

  1989cited by this paper
• The effects of hypoxemia on cardiac output. A dose-response curve.

  1988cited by this paper
• Correction of systolic time intervals for heart rate: a comparison of individual with population derived regression equations.

  1988cited by this paper
• Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation.

  1984cited by this paper
• Cardiopulmonary effects of fenoterol and salbutamol aerosols.

  1980cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• A critical review of the systolic time intervals.

  1977cited by this paper
• Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.

  1976cited by this paper
• Torsade De Pointes, an atypical ventricular tachycardia.

  1976cited by this paper
• The cardio‐toxicity of isoprenaline during hypoxia

  1969cited by this paper
• Comparative circulatory responses to systemic hypoxia in man and in unanesthetized dog.

  1967cited by this paper
• Review of Medical Physiology.

  1966cited by this paper
• Cardiovascular responses to ischemia, hypoxia, and hypercapnia of the central nervous system

  1963cited by this paper

• Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.

  2023cites this paper
• Response After Fenoterol inHypoxemic Patients With Stable COPD

  2017cites this paper
• clinical investigations Left Ventricular Systolic Performance During AcuteHypoxemia

  2017cites this paper
• Evaluation of pharmacotherapy of obstructive airway diseases in the Montenegrin outpatient care: comparison with two Scandinavian countries

  2012cites this paper
• Long-Acting β2-Agonists

  2012cites this paper
• Asthma in the elderly: What we do not know yet but should find out.

  2011cites this paper
• Prolongation of the Corrected QT Complex – A Cause of Sudden Cardiac Death in the Mountain Environment?

  2011cites this paper
• [Safety and tolerability of bronchodilators in chronic obstructive pulmonary disease].

  2009cites this paper
• Safety aspect of β2-agonists in chronic obstructive pulmonary diesease

  2009cites this paper
• Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study.

  2007cites this paper
• Effects of hypercapnia and hypoxemia on respiratory sinus arrhythmia in conscious humans during spontaneous respiration.

  2007cites this paper
• in conscious humans during spontaneous respiration

  2007cites this paper
• Current issues with beta2-adrenoceptor agonists: historical background.

  2006cites this paper
• The rapid and effective administration of a S 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers

  2006cites this paper
• Current issues with β2-adrenoceptor agonists

  2006cites this paper
• Cardiovascular Effects of -Agonists in Patients With Asthma and COPD*

  2006cites this paper
• Time to death, airway wall inflammation and remodelling in fatal asthma

  2005cites this paper
• DYSFONCTION CARDIAQUE AUTONOME DANS LA MALADIE PULMONAIRE OBSTRUCTIVE CHRONIQUE Récupération de la fréquence cardiaque après un exercice: facteur prédictif de mortalité dans la maladie pulmonaire obstructive chronique

  2005cites this paper
• Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

  2004cites this paper
• Cardiovascular Safety of β2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease

  2004cites this paper
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

  2004cites this paper
• Drugs acting on the respiratory tract

  2003cites this paper
• Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

  2002cites this paper
• Antiobstruktive antiinflammatorische Therapie: ohne Probleme in der Pneumologie, problematisch in der Kardiologie?

  2002cites this paper
• Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study.

  2002cites this paper
• Adverse effects of beta-agonists.

  2002cites this paper
• Inhibition by fenoterol of human eosinophil functions including β2‐adrenoceptor‐independent actions

  2002cites this paper
• [Anti-obstructive anti-inflammatory therapy: no problems in pneumology, problematic in cardiology?].

  2002cites this paper
• Adverse effects of -agonists

  2002cites this paper
• Fatal asthma and the environment

  2002cites this paper
• Short-Acting Beta-Agonist Research: A Perspective

  2001cites this paper
• Revisiting interactions between hypoxaemia and beta2 agonists in asthma.

  2001cites this paper
• Long-Acting β2 Agonists in the Management of Stable Chronic Obstructive Pulmonary Disease

  2000cites this paper
• Cardiopulmonary interactions of hypoxia and hypercapnia and the role of vasoactive mediators in the pulmonary circulation in man

  2000cites this paper
• Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.

  2000cites this paper
• The natural history of asthma in adults: the problem of irreversibility.

  1999cites this paper
• β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?

  1999cites this paper
• Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

  1999cites this paper
• Cardiac Effects of β-Agonists in Patients with COPD

  1998cites this paper
• The extrapulmonary effects of increasing doses of formoterol in patients with asthma

  1998cites this paper
• ß-Adrenoceptor Agonists

  1998cites this paper
• Cardiac effects of beta-agonists in patients with COPD.

  1998cites this paper
• Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.

  1998cites this paper
• Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.

  1996cites this paper
• Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD.

  1996cites this paper
• Left ventricular systolic performance during acute hypoxemia.

  1995cites this paper
• Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol.

  1995cites this paper
• Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers.

  1995cites this paper
• The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers.

  1994cites this paper
• The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

  1994cites this paper
• The effect of hypercapnia and hypoxemia on the cardiovascular responses to isoproterenol

  1994cites this paper
• Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed.

  1994cites this paper
• The β2-Agonist Controversy

  1994cites this paper